{"title":"Balloon inflation for a mechanical tricuspid valve thrombosis: case report.","authors":"Shaw Hua Anthony Kueh, Mark Webster","doi":"10.1093/ehjcr/ytaf367","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mechanical valve thrombosis (MVT) is rare but life-threatening complication. While the clinical guideline suggests that thrombolysis for high-risk surgical candidates should be considered, the European guideline does not differentiate between left- and right-sided MVTs while the American guideline only made specific recommendations for left-sided MVT. Furthermore, the American guideline suggests that percutaneous intervention for left-sided MVT may be considered. Both clinical guidelines did not refer to percutaneous intervention for right-sided MVT.</p><p><strong>Case summary: </strong>A 52-year-old woman with three mechanical valve replacements for rheumatic heart disease presented with subacute onset of symptoms of right-sided heart failure. Transthoracic echocardiogram (TTE) demonstrated a high transvalvular gradient across the tricuspid mechanical valve which is new from TTE 3 years prior. Further imaging confirmed thrombosis of the anterior leaflet of the tricuspid mechanical valve. Four cycles of ultra-low-dose thrombolysis and one standard-dose thrombolysis failed to restore normal valve function. Surgery was considered prohibitively high-risk, and the patient was left with either palliation or percutaneous intervention. Percutaneous mechanical valve balloon inflation was undertaken with subsequent improvement in transvalvular gradient and leaflet motion.</p><p><strong>Discussion: </strong>There is limited data on percutaneous intervention for right-sided MVT with only one other case reported to date. In patients with prohibitively high surgical risk, thrombolysis should be considered as per the clinical guidelines. However, in ∼1 in 10 patients, thrombolysis fails to restore normal valve function. Percutaneous intervention may be an alternative option.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 8","pages":"ytaf367"},"PeriodicalIF":0.8000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342785/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal: Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjcr/ytaf367","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Mechanical valve thrombosis (MVT) is rare but life-threatening complication. While the clinical guideline suggests that thrombolysis for high-risk surgical candidates should be considered, the European guideline does not differentiate between left- and right-sided MVTs while the American guideline only made specific recommendations for left-sided MVT. Furthermore, the American guideline suggests that percutaneous intervention for left-sided MVT may be considered. Both clinical guidelines did not refer to percutaneous intervention for right-sided MVT.
Case summary: A 52-year-old woman with three mechanical valve replacements for rheumatic heart disease presented with subacute onset of symptoms of right-sided heart failure. Transthoracic echocardiogram (TTE) demonstrated a high transvalvular gradient across the tricuspid mechanical valve which is new from TTE 3 years prior. Further imaging confirmed thrombosis of the anterior leaflet of the tricuspid mechanical valve. Four cycles of ultra-low-dose thrombolysis and one standard-dose thrombolysis failed to restore normal valve function. Surgery was considered prohibitively high-risk, and the patient was left with either palliation or percutaneous intervention. Percutaneous mechanical valve balloon inflation was undertaken with subsequent improvement in transvalvular gradient and leaflet motion.
Discussion: There is limited data on percutaneous intervention for right-sided MVT with only one other case reported to date. In patients with prohibitively high surgical risk, thrombolysis should be considered as per the clinical guidelines. However, in ∼1 in 10 patients, thrombolysis fails to restore normal valve function. Percutaneous intervention may be an alternative option.